ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study

W. S. Velasquez, P. McLaughlin, Susan L Tucker, Fredrick B Hagemeister, F. Swan, M. A. Rodriguez, Jorge E Romaguera, E. Rubenstein, F. Cabanillas

Research output: Contribution to journalArticlepeer-review

414 Scopus citations

Fingerprint

Dive into the research topics of 'ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study'. Together they form a unique fingerprint.

Medicine & Life Sciences